Inside the research

AptarGroup, Inc.

ATR Research profile · latest available data

Price overview

$123.87

▲ +0.49 (+0.4%)

52w hi$144.64
52w lo$111.55
Vol325.60K
As of25 Sep 2026

The Verdict

Hold

Our score -0.12

Short-0.23
Medium-0.04
Long-0.06

computed 2026-09-27

Key fundamentals

AptarGroup, Inc.

Healthcare · Medical Instruments & Supplies

Market cap$7.88B
Enterprise value$9.14B
Trailing P/E22.36x
Forward P/E19.61x
EV / EBITDA11.44x
P / S (ttm)2.00x
Profit margin9.2%
Return on equity13.5%
Revenue growth+6.3%
Earnings growth-18.6%
Debt / equity52.78

Layer Breakdown

LayerRawContribution
Fundamental+0.14
Sector+0.08
Technical-0.17
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

United States · www.aptar.com

Risk Metrics

Beta vs SPX0.61
Corr SPX0.41
Annual vol24.3%
Annual ret-8.5%
Sharpe-0.35
Max DD-36.5%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$163.29
High / Low$220.00 / $145.00
Median$156.00
Analysts7
Strong Buy1
Buy4
Hold2
Sell0
Strong Sell0

Recent rating actions

2026-05-04Wells Fargo→ Overweight
2026-03-20Wells Fargo→ Overweight
2026-01-06Wells Fargo→ Equal-Weight
2025-11-03Wells Fargo→ Overweight
2025-11-03Baird→ Outperform
2025-09-10Wells Fargo→ Overweight

Material Events

DateEvent8-K
2026-07-30Earnings Release, Exhibitsread
2026-05-13Officer / Director Changeread
2026-05-07Shareholder Voteread
2026-04-30Earnings Release, Exhibitsread
2026-03-17Officer / Director Change, Exhibitsread
2026-02-05Earnings Release, Exhibitsread
2025-11-20Material Agreement, Other Material Event…read
2025-10-30Earnings Release, Exhibitsread
2025-07-31Earnings Release, Exhibitsread
2025-05-08Officer / Director Change, Shareholder Vote…read
2025-05-01Earnings Release, Exhibitsread
2025-02-06Earnings Release, Exhibitsread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-04Prieur MarcSegment PresidentSell3.38K$459.90K
2026-08-04Prieur MarcSegment PresidentSell124$17.00K
2026-08-03Tanda Stephan B.President and CEOOption exercise9.84K$735.78K
2026-08-03Tanda Stephan B.President and CEOSell9.84K$1.34M
2026-08-03Tlili HediSegment PresidentSell8.85K$1.20M
2026-07-16FOTIADES GEORGE LGrant151—
2026-07-16Kampouri Monnas GiovannaGrant151—
2026-07-16Marey-Semper IsabelGrant151—
2026-07-16Matthews Candace S.Grant226—
2026-07-16Wunderlich Ralf K.Grant151—

Flow & Concentration

Insider 180d net-$3.01M
Insider buys / sells0 / 4
Insider biasSellers
13F holders8
Top-5 share95.4%
HHI3,575 (concentrated)

Top Holders

HolderValueShares
State Street Corp$358.50M2.86M
Fidelity / FMR LLC$134.44M1.07M
AQR Capital Management$84.71M680.21K
Citadel Advisors$30.67M244.96K
Renaissance Technologies$21.33M170.40K
Millennium Management$19.48M155.57K
Capital Research / Capital World$10.69M85.36K
T. Rowe Price Group$7.74K61.79K

As of 2026-06-30

Dividends

Yield (TTM)1.16%
$ / share (TTM)$1.44
5y CAGR+4.9%

Annual dividend per share

2021$1.50
2022$1.52
2023$1.58
2024$1.72
2025$1.83
2026$0.96

SEC Filings

DateFormDoc
2026-08-054view
2026-08-044view
2026-08-034view
2026-07-3110-Qview
2026-07-308-Kview
2026-07-174view
2026-07-174view
2026-07-174view
2026-07-174view
2026-07-174view
2026-07-174view
2026-07-174view
2026-07-174view
2026-07-174view
2026-06-164view

The Long Run

FY 2010–2025 · 16 years

LineLatestCAGRTrend
Revenue$3.78B+4.9%
Gross profit$233.84M-9.4%
Operating income$496.50M+5.1%
Net income$392.79M+26.5%
Cash from ops$570.00M+9.0%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$123.76$124.05$122.42$123.87325.60K
Sep 24$124.51$124.99$122.32$123.38377.20K
Sep 23$125.43$125.72$124.50$124.74335.30K
Sep 22$124.72$125.80$123.83$125.45417.70K
Sep 21$124.84$125.98$123.32$123.40424.40K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →